PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 95 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,113,738 | -68.9% | 107,400 | -57.0% | 0.00% | – |
| Q2 2023 | $3,577,251 | +48.2% | 249,808 | -26.1% | 0.00% | – |
| Q1 2023 | $2,414,148 | +709.9% | 338,116 | +1172.7% | 0.00% | – |
| Q4 2022 | $298,082 | -73.1% | 26,567 | -73.4% | 0.00% | – |
| Q3 2022 | $1,108,000 | +73.9% | 99,999 | +32.4% | 0.00% | – |
| Q2 2022 | $637,000 | +34.1% | 75,500 | +116.3% | 0.00% | – |
| Q1 2022 | $475,000 | +40.1% | 34,900 | +249.0% | 0.00% | – |
| Q2 2021 | $339,000 | -66.0% | 10,000 | -62.3% | 0.00% | – |
| Q1 2021 | $996,000 | -69.9% | 26,505 | -73.4% | 0.00% | – |
| Q4 2020 | $3,306,000 | – | 99,518 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |